Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | EQ 600MG BASE;300MG | 0 | ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-11-15 | STANDARD |
Submissions Property Types
CDER Filings
ZYDUS PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 208990
[companyName] => ZYDUS PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"ABACAVIR SULFATE AND LAMIVUDINE","activeIngredients":"ABACAVIR SULFATE; LAMIVUDINE","strength":"EQ 600MG BASE;300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/15\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"07\/23\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-07-23
)
)